Back to Cymra Life Sciences or All Oil Concentrates

Dosing Look-Up Table (Estimated)

0.01/g1/mg THC2.5/mg CBD
0.05/g5/mg THC12.5/mg CBD
0.1/g10/mg THC25/mg CBD
0.15/g15/mg THC37.5/mg CBD
0.2/g20/mg THC50/mg CBD
0.25/g25/mg THC62.5/mg CBD
0.3/g30/mg THC75/mg CBD
/gCalculate THCCalculate CBD

Please note values above are based on registered THC/CBD percentages, subject to ±10% allowed variance. Values provided are 'best case', losses to air during vaporisation or combustion will always occur.

Medication Details

Brand
Australia Cymra Life Sciences
Designation
Cybis T10:C25
Chemotype
Type II: THC/CBD Mix
THC Potential Range (±10%)
9-11/mg
CBD Potential Range (±10%)
22.5-27.5/mg
Cultivated or Packaged in
Flag of Australia Australia
Imported by
United Kingdom Script Assist

Stock Availability

We provide stock/pharmacy information only for use by medical cannabis patients, clinicians and pharmacists*.

Best-Known Status: Not Yet Available

We try to ascertain stock status strictly based on the importer/distributor supplying pharmacies. Availability at individual pharmacies will differ.

*Cannabis is a controlled-substance and can only be legally dispensed upon submission of a valid prescription from a prescribing clinic, ordinarily listed.

Main Partner Pharmacy

Pharmacy Distributor

Dispensing Patient Pharmacies

Product DescriptionPatient Reviews

Australia About Cymra Life Sciences Ltd.

Cymra Life Sciences Logo

We’ve set out to cultivate full spectrum medicines to enhance the lives of people living in chronic and neuropathic pain.

Cymra Life Sciences is an Australian owned licenced and permitted cultivator and manufacturer of medical cannabis from the Australian Office of Drug Control.

We've set out to cultivate full spectrum medicines to enhance the lives of people living in chronic and neuropathic pain.

We are focused on the development of cannabis medicines for chronic and neuropathic pain.

WHY? We don’t believe there is good long term medication options for chronic pain conditions (i.e opiates) are a good long term medication and have serious side effects.

We’re one of the first Australian companies to develop medical cannabis through tissue culture propagation, a method which delivers a consistent, natural product, free from pests and chemical dependencies. The team at Cymra Life Sciences is innovative, ambitious and fast-moving, all backed up by years of experience across pain management, medical research, plant genetics and breeding.

cymra.com.au

  Information provided is partially -sourced and may be outdated or otherwise incorrect. Please report any inaccuracies found by email.

NHS LogoFurther National Health-Service Information on Cannabis-Based Products for Medicinal Use (CBPMs)